CapsoVision CV
NASDAQ CV
$6.37 +0.01 (+0.16%)
At close: Sep 9, 2026 · 4:00 PM EDT

CapsoVision (CV) Invested Capital (2024 - 2025)

CapsoVision's (CV) quarterly Invested Capital came in at -$138.0 million in Q2 2025, down 6.54% quarter-over-quarter from -$129.5 million in Q4 2024.

Analysis

CapsoVision (CV) Invested Capital (2024 - 2025) Analysis & Trends

CapsoVision has disclosed Invested Capital across 2 years of filings, most recently posting -$138.0 million for Q2 2025.

  • In Q2 2025, Invested Capital changed N/A year-over-year to -$138.0 million; the TTM figure through Jun 2025 stood at -$138.0 million (changed N/A YoY), while the FY2024 annual figure was -$129.5 million, changed N/A from the prior year.
  • Invested Capital came in at -$138.0 million for Q2 2025 at CapsoVision, down from -$129.5 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of -$129.5 million in Q4 2024 to a low of -$138.0 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 GE HealthCare Technologies 29.54 Bn 27.44 Bn 2.18 Bn 21.09 Bn
2 Lantheus Holdings 6.56 Bn 5.97 Bn 241.86 Mn 1.88 Bn
3 Heartflow 4.04 Bn 3.66 Bn 53.19 Mn -
4 Neogen 2.59 Bn 2.41 Bn 107.80 Mn 2.89 Bn
5 Butterfly Network 1.96 Bn 1.84 Bn 23.29 Mn -
6 Ceribell 928.74 Mn 799.48 Mn 25.94 Mn 148.29 Mn
7 QuidelOrtho 866.04 Mn 742.64 Mn - 4.67 Bn
8 Varex Imaging 779.06 Mn 679.86 Mn 76.70 Mn 875.80 Mn
9 Prenetics Global 339.99 Mn 280.94 Mn 30.20 Mn -
10 CapsoVision 318.60 Mn 309.52 Mn 1.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -137.99 Mn
Dec 31, 2024 -129.51 Mn